Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Clinical Pharmacology and Therapeutics
|
July 23, 2013
CYP2D6 genotype should not be used to determine endocrine therapy in postmenopausal breast cancer patients
J M Rae
The Pharmacogenomics Journal
|
March 12, 2003
Cytochrome P450 3A pharmacogenetics: the road that needs traveled
D A Flockhart, J M Rae
The Australasian Journal of Dermatology
|
December 1, 1982
Epithelioid leiomyoma: a case report
L A Musso, J M Rae
HIV Medicine
|
April 23, 2010
Efavirenz directly modulates the oestrogen receptor and induces breast cancer cell growth
M J Sikora, J M Rae, M D Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 21, 2001
Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays
J M Rae, M D Johnson, M E Lippman, et al.
The Pharmacogenomics Journal
|
June 16, 2010
High-efficiency genotype analysis from formalin-fixed, paraffin-embedded tumor tissues
M J Sikora, J N Thibert, J Salter, et al.
Breast Cancer Research and Treatment
|
July 19, 2017
Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome
P Miller, K M Kidwell, D Thomas, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
December 13, 2017
Functional characterization of the G162R and D216H genetic variants of human CYP17A1
C P Capper, J Liu, L R McIntosh, et al.
Molecular and Cellular Endocrinology
|
March 14, 2017
Steroid receptor coactivator-1 can regulate osteoblastogenesis independently of estrogen
R J Watters, R J Hartmaier, H U Osmanbeyoglu, et al.
Breast Cancer Research and Treatment
|
October 21, 2009
Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody
H J Hnatyszyn, M Liu, A Hilger, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Clinical Pharmacology and Therapeutics
|
July 23, 2013
CYP2D6 genotype should not be used to determine endocrine therapy in postmenopausal breast cancer patients
J M Rae
The Pharmacogenomics Journal
|
March 12, 2003
Cytochrome P450 3A pharmacogenetics: the road that needs traveled
D A Flockhart, J M Rae
The Australasian Journal of Dermatology
|
December 1, 1982
Epithelioid leiomyoma: a case report
L A Musso, J M Rae
HIV Medicine
|
April 23, 2010
Efavirenz directly modulates the oestrogen receptor and induces breast cancer cell growth
M J Sikora, J M Rae, M D Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 21, 2001
Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays
J M Rae, M D Johnson, M E Lippman, et al.
The Pharmacogenomics Journal
|
June 16, 2010
High-efficiency genotype analysis from formalin-fixed, paraffin-embedded tumor tissues
M J Sikora, J N Thibert, J Salter, et al.
Breast Cancer Research and Treatment
|
July 19, 2017
Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome
P Miller, K M Kidwell, D Thomas, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
December 13, 2017
Functional characterization of the G162R and D216H genetic variants of human CYP17A1
C P Capper, J Liu, L R McIntosh, et al.
Molecular and Cellular Endocrinology
|
March 14, 2017
Steroid receptor coactivator-1 can regulate osteoblastogenesis independently of estrogen
R J Watters, R J Hartmaier, H U Osmanbeyoglu, et al.
Breast Cancer Research and Treatment
|
October 21, 2009
Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody
H J Hnatyszyn, M Liu, A Hilger, et al.
Page
of 2